USD 16.17
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2024 | 107.54 Billion JPY | 19.36% |
2023 | 90.1 Billion JPY | 15.89% |
2022 | 77.74 Billion JPY | 26.41% |
2021 | 61.5 Billion JPY | 8.77% |
2020 | 56.54 Billion JPY | -1.17% |
2019 | 57.21 Billion JPY | 14.15% |
2018 | 50.12 Billion JPY | 17.36% |
2017 | 42.7 Billion JPY | 8.1% |
2016 | 39.51 Billion JPY | 11.86% |
2015 | 35.32 Billion JPY | 25.5% |
2014 | 28.14 Billion JPY | 40.95% |
2013 | 19.96 Billion JPY | 34.45% |
2012 | 14.85 Billion JPY | -7.22% |
2011 | 16 Billion JPY | 4.35% |
2010 | 15.33 Billion JPY | 20.61% |
2009 | 12.71 Billion JPY | 8.7% |
2008 | 11.7 Billion JPY | 0.49% |
2007 | 11.64 Billion JPY | 17.8% |
2006 | 9.88 Billion JPY | 25.29% |
2005 | 7.88 Billion JPY | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q4 | 26.81 Billion JPY | 1.6% |
2024 Q3 | 26.39 Billion JPY | 2.98% |
2024 Q1 | 28.71 Billion JPY | 41.26% |
2024 Q2 | 25.62 Billion JPY | -10.74% |
2023 Q2 | 22.77 Billion JPY | 0.53% |
2023 FY | 90.1 Billion JPY | 15.89% |
2023 Q4 | 20.32 Billion JPY | -16.48% |
2023 Q1 | 22.65 Billion JPY | 7.57% |
2023 Q3 | 24.33 Billion JPY | 6.86% |
2022 Q4 | 21.06 Billion JPY | 10.97% |
2022 FY | 77.74 Billion JPY | 26.41% |
2022 Q3 | 18.98 Billion JPY | -3.06% |
2022 Q2 | 19.58 Billion JPY | 8.07% |
2022 Q1 | 18.12 Billion JPY | 8.48% |
2021 Q3 | 16.5 Billion JPY | 18.77% |
2021 Q4 | 16.7 Billion JPY | 1.22% |
2021 Q2 | 13.89 Billion JPY | -3.56% |
2021 FY | 61.5 Billion JPY | 8.77% |
2021 Q1 | 14.4 Billion JPY | 29.34% |
2020 FY | 56.54 Billion JPY | -1.17% |
2020 Q4 | 11.13 Billion JPY | -22.96% |
2020 Q1 | 15.51 Billion JPY | 7.34% |
2020 Q2 | 15.43 Billion JPY | -0.5% |
2020 Q3 | 14.45 Billion JPY | -6.32% |
2019 FY | 57.21 Billion JPY | 14.15% |
2019 Q4 | 14.45 Billion JPY | -3.4% |
2019 Q3 | 14.96 Billion JPY | 6.24% |
2019 Q2 | 14.08 Billion JPY | 2.62% |
2019 Q1 | 13.72 Billion JPY | 16.67% |
2018 Q3 | 12.95 Billion JPY | 0.87% |
2018 Q2 | 12.84 Billion JPY | 2.16% |
2018 Q1 | 12.56 Billion JPY | 12.92% |
2018 Q4 | 11.76 Billion JPY | -9.19% |
2018 FY | 50.12 Billion JPY | 17.36% |
2017 Q3 | 11.17 Billion JPY | 7.31% |
2017 Q1 | 9.98 Billion JPY | 8.98% |
2017 Q4 | 11.13 Billion JPY | -0.41% |
2017 Q2 | 10.41 Billion JPY | 4.27% |
2017 FY | 42.7 Billion JPY | 8.1% |
2016 Q3 | 10.39 Billion JPY | 7.0% |
2016 Q1 | 10.23 Billion JPY | 10.54% |
2016 FY | 39.51 Billion JPY | 11.86% |
2016 Q4 | 9.16 Billion JPY | -11.84% |
2016 Q2 | 9.71 Billion JPY | -5.07% |
2015 Q4 | 9.25 Billion JPY | 1.67% |
2015 Q1 | 8.24 Billion JPY | 12.08% |
2015 FY | 35.32 Billion JPY | 25.5% |
2015 Q3 | 9.1 Billion JPY | 4.54% |
2015 Q2 | 8.71 Billion JPY | 5.63% |
2014 Q2 | 6.96 Billion JPY | 12.38% |
2014 Q3 | 7.61 Billion JPY | 9.29% |
2014 Q4 | 7.35 Billion JPY | -3.39% |
2014 FY | 28.14 Billion JPY | 40.95% |
2014 Q1 | 6.2 Billion JPY | 14.79% |
2013 Q2 | 5.06 Billion JPY | 11.36% |
2013 Q3 | 4.94 Billion JPY | -2.36% |
2013 Q4 | 5.4 Billion JPY | 9.17% |
2013 FY | 19.96 Billion JPY | 34.45% |
2013 Q1 | 4.55 Billion JPY | 17.18% |
2012 Q3 | 3.06 Billion JPY | -7.55% |
2012 Q1 | 4.58 Billion JPY | 15.43% |
2012 Q2 | 3.31 Billion JPY | -27.53% |
2012 FY | 14.85 Billion JPY | -7.22% |
2012 Q4 | 3.88 Billion JPY | 26.55% |
2011 Q3 | 4.1 Billion JPY | 6.68% |
2011 Q1 | 4.07 Billion JPY | 5.49% |
2011 FY | 16 Billion JPY | 4.35% |
2011 Q4 | 3.96 Billion JPY | -3.43% |
2011 Q2 | 3.85 Billion JPY | -5.57% |
2010 Q3 | 4.06 Billion JPY | 13.31% |
2010 FY | 15.33 Billion JPY | 20.61% |
2010 Q4 | 3.86 Billion JPY | -4.87% |
2010 Q1 | 3.82 Billion JPY | 9.81% |
2010 Q2 | 3.58 Billion JPY | -6.16% |
2009 Q1 | 3.21 Billion JPY | 0.0% |
2009 Q4 | 3.48 Billion JPY | 11.36% |
2009 Q3 | 3.12 Billion JPY | 7.74% |
2009 Q2 | 2.9 Billion JPY | -9.64% |
2009 FY | 12.71 Billion JPY | 8.7% |
2008 FY | 11.7 Billion JPY | 0.49% |
2007 FY | 11.64 Billion JPY | 17.8% |
2006 FY | 9.88 Billion JPY | 25.29% |
2005 FY | 7.88 Billion JPY | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
American Medical Technologies Inc. | 3.19 Million USD | -3369722.22% |
Ansell Limited | 1.61 Billion USD | -6541.574% |
Ansell Limited | 1.61 Billion USD | -6541.574% |
BG Medicine, Inc. | - USD | -Infinity% |
Biotage AB (publ) | 184.64 Million USD | -58144.498% |
BioLife Sciences Inc. | - USD | -Infinity% |
CB Scientific, Inc. | 135.05 Thousand USD | -79631901.777% |
Psykey, Inc. | 419.29 Thousand USD | -25649138.372% |
ConvaTec Group Plc | 2.19 Billion USD | -4801.834% |
ConvaTec Group Plc | 2.14 Billion USD | -4919.931% |
Encision Inc. | 6.58 Million USD | -1632893.121% |
Golden Valley Development, Inc | - USD | -Infinity% |
Hear AtLast Holdings, Inc. | - USD | -Infinity% |
Innovative MedTech Inc. | 1.82 Million USD | -5893128.489% |
LifePoint, Inc. | -18.5 Thousand USD | 581335235.135% |
Medite Cancer Diagnostics, Inc. | 6.81 Million USD | -1578455.702% |
Paradigm Medical Industries, Inc. | 772 Thousand USD | -13930858.549% |
QuantRx Biomedical Corporation | - USD | -Infinity% |
Remedent, Inc. | 986.22 Thousand USD | -10904870.493% |
Reflect Scientific, Inc. | 1.08 Million USD | -9956535.813% |
SmileDirectClub, Inc. | 470.74 Million USD | -22746.224% |
Sector 10, Inc. | - USD | -Infinity% |
Shandong Weigao Group Medical Polymer Company Limited | 1.87 Billion USD | -5646.232% |
SheerVision, Inc. | 3.49 Million USD | -3073192.132% |
United Health Products, Inc. | - USD | -Infinity% |
Vasamed, Inc. | 1.38 Million USD | -7757778.199% |
Wearable Health Solutions, Inc. | 745.09 Thousand USD | -14433937.093% |
Yubo International Biotech Limited | 104.28 Thousand USD | -103129844.478% |